Search

Kyungjin Kim Phones & Addresses

  • Brooklyn, NY
  • New Haven, CT
  • Evansville, IN

Professional Records

License Records

Kyungjin Kim

License #:
10944 - Expired
Issued Date:
Sep 30, 1987
Renew Date:
Jun 1, 2002
Expiration Date:
May 31, 2004
Type:
Certified Public Accountant

Publications

Us Patents

Substituted Piperidines

View page
US Patent:
6916833, Jul 12, 2005
Filed:
Mar 4, 2004
Appl. No.:
10/793296
Inventors:
Kyungjin Kim - Livingston NJ, US
Emily Aijun Liu - Nutley NJ, US
Steven Gregory Mischke - Florham Park NJ, US
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
A61K031/445
C07D211/40
C07D211/50
C07D211/42
US Classification:
514328, 546217
Abstract:
The present invention provides compounds having formula (I): and formula (II): wherein X, n, and R-Rare defined herein, or a pharmaceutically acceptable salt thereof. The invention also provides a pharmaceutical composition comprising a therapeutically effective amount of a compound represented by formula (I) or (II) and a pharmaceutically acceptable carrier or excipient. The invention further provides a method for treating cancer comprising administering to a patient in need of such treatment a therapeutically effective amount of a compound represented by formula (I) or (II).

Substituted Piperidines

View page
US Patent:
7060713, Jun 13, 2006
Filed:
Mar 18, 2005
Appl. No.:
11/083750
Inventors:
Kyungjin Kim - Livingston NJ, US
Emily Aijun Liu - Nutley NJ, US
Steven Gregory Mischke - Florham Park NJ, US
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
A61K 31/445
C07D 211/40
C07D 211/44
US Classification:
514328, 546216, 546217
Abstract:
The present invention provides compounds having formula (II):.

Mch Receptor Antagonists

View page
US Patent:
7803816, Sep 28, 2010
Filed:
Sep 25, 2006
Appl. No.:
11/526523
Inventors:
Steven Joseph Berthel - Mendham Township NJ, US
Shawn David Erickson - Leonia NJ, US
Nader Fotouhi - Basking Ridge NJ, US
Robert Francis Kester - West Orange NJ, US
Kyungjin Kim - Livingston NJ, US
Steven Gregory Mischke - Florham Park NJ, US
Yimin Qian - Wayne NJ, US
Kshitij Chhabilbhai Thakkar - Clifton NJ, US
Jefferson Wright Tilley - North Caldwell NJ, US
Hong Wang - Nutley NJ, US
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
A61K 31/454
C07D 403/02
US Classification:
514322, 546199
Abstract:
Provided herein are compounds of the formula (I):.

Gpr119 Receptor Agonists

View page
US Patent:
8188098, May 29, 2012
Filed:
May 1, 2009
Appl. No.:
12/433921
Inventors:
Shawn David Erickson - Leonia NJ, US
Paul Gillespie - Westfield NJ, US
Kevin Richard Guertin - Verona NJ, US
Prabha Saba Karnachi - Hillsborough NJ, US
Kyungjin Kim - Livingston NJ, US
Chun Ma - Edgewater NJ, US
Warren William McComas - Denville NJ, US
Lida Qi - Leonia NJ, US
Jefferson Wright Tilley - North Caldwell NJ, US
Qiang Zhang - Parsippany NJ, US
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
A01N 43/90
A61K 31/519
C07D 487/00
US Classification:
5142621, 544262
Abstract:
Provided herein are compounds of the formula (I):.

4-Phenoxy-Nicotinamide Or 4-Phenoxy-Pyrimidine-5-Carboxamide Compounds

View page
US Patent:
8420647, Apr 16, 2013
Filed:
Jan 13, 2011
Appl. No.:
13/005566
Inventors:
Caterina Bissantz - Village-Neuf, FR
Henrietta Dehmlow - Loerrach, DE
Shawn David Erickson - Leonia NJ, US
Kyungjin Kim - Livingston NJ, US
Rainer E. Martin - Basel, CH
Ulrike Obst Sander - Reinach BL, CH
Hans Richter - Grenzach-Wyhlen, DE
Christoph Ulmer - Fischingen, DE
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
A61K 31/498
US Classification:
514249, 544353
Abstract:
This invention relates to novel phenyl amide or pyridyl amide derivatives of the formula.

Diaminopyrroloquinazolines Compounds As Protein Tyrosine Phosphatase Inhibitors

View page
US Patent:
7262297, Aug 28, 2007
Filed:
Apr 30, 2004
Appl. No.:
10/836507
Inventors:
Steven Joseph Berthel - Mendham Township NJ, US
Adrian Wai-Hing Cheung - Glen Rock NJ, US
Kyungjin Kim - Livingston NJ, US
Kshitij Chhabilbhai Thakkar - Nutley NJ, US
Weiya Yun - Warren NJ, US
Assignee:
Hoffmann-La Roche Inc. - Nutley NJ
International Classification:
C07D 239/00
C07D 487/00
US Classification:
544249, 544250
Abstract:
The invention relates to pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds which are useful for inhibiting protein tyrosine phosphatases, particularly PTP1B, and are useful for lowering blood glucose concentrations in mammals.

Diaminothiazoles Having Antiproliferative Activity

View page
US Patent:
20020151554, Oct 17, 2002
Filed:
Jan 9, 2002
Appl. No.:
10/042619
Inventors:
Li Chen - Westfield NJ, US
Qingjie Ding - Bridgewater NJ, US
Paul Gillespie - Westfield NJ, US
Kyungjin Kim - Livingston NJ, US
Allen Lovey - North Caldwell NJ, US
Warren McComas - Denville NJ, US
John Mullin - Hawthorne NJ, US
Agostino Perrotta - Bloomfield NJ, US
International Classification:
A61K031/496
C07D417/02
US Classification:
514/254020, 544/369000
Abstract:
Disclosed are novel diaminothiazoles that are selective inhibitors of Cdk4. These compounds and their pharmaceutically acceptable salts and esters are anti-proliferative agents useful in the treatment or control of solid tumors, in particular breast, colon, lung and prostate tumors. Also disclosed are pharmaceutical compositions containing these compounds as well as intermediates useful in the preparation of the compounds.

Pyridopyrimidine Protein Tyrosine Phosphatase Inhibitors

View page
US Patent:
20070021445, Jan 25, 2007
Filed:
Jul 18, 2006
Appl. No.:
11/488863
Inventors:
Steven Berthel - Mendham Township NJ, US
Adrian Cheung - Glen Rock NJ, US
Kyungjin Kim - Livingston NJ, US
Shiming Li - Edison NJ, US
Kshitij Thakkar - Clifton NJ, US
Weiya Yun - Warren NJ, US
International Classification:
A61K 31/519
C07D 487/04
US Classification:
514264110, 544279000
Abstract:
The present invention comprises pyridopyrimidinediamine compounds of the general formula I: The compounds of the present invention are potent inhibitors of PTP1B. Accordingly, the invention also encompasses pharmaceutical compositions and methods of treating or preventing PTP-1B mediated diseases, including diabetes, obesity, and diabetes-related diseases.
Kyungjin Kim from Brooklyn, NY Get Report